Advertisement
Screener

TG THERAPEUTICS, INC. (TGTX) Increase (Decrease) in Other Noncurrent Assets

2.8 / 5 stars · 68/120 Roast Me

TG THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets

TG THERAPEUTICS, INC. (TGTX) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2020-03-02

  • TG THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2018-12-31 was $0.00.
  • TG THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
  • TG THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2018-06-30 was $0.00.
  • TG THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2018-03-31 was $0.00.
  • TG THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2019 was $0.00.
  • TG THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2018 was $0.00.
  • TG THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2017 was -$162.00K, a 3340.00% decline from fiscal 2016.
  • TG THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2016 was $5.00K, a 88.02% decline from fiscal 2015.
Period endIncrease (Decrease) in Other Noncurrent Assets 3 monthIncrease (Decrease) in Other Noncurrent Assets 3 month as first filedIncrease (Decrease) in Other Noncurrent Assets 6 monthIncrease (Decrease) in Other Noncurrent Assets 6 month as first filedIncrease (Decrease) in Other Noncurrent Assets 9 monthIncrease (Decrease) in Other Noncurrent Assets 9 month as first filedIncrease (Decrease) in Other Noncurrent Assets 12 monthIncrease (Decrease) in Other Noncurrent Assets 12 month as first filedIncrease (Decrease) in Other Noncurrent Assets 19 monthIncrease (Decrease) in Other Noncurrent Assets 22 monthIncrease (Decrease) in Other Noncurrent Assets 25 monthIncrease (Decrease) in Other Noncurrent Assets 28 month
2019-12-31$0.00
10-K · filed 2020-03-02
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$0.00
derived: sum of 2 quarters · filed 2020-03-02
$0.00
derived: sum of 3 quarters · filed 2020-03-02
$0.00
10-K · filed 2020-03-02
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$0.00
derived: sum of 2 quarters · filed 2018-11-09
$0.00
10-Q · filed 2018-11-09
$0.00
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$0.00
10-Q · filed 2018-08-09
$0.00
derived: sum of 3 quarters · filed 2020-03-02
$233.00K
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$0.00
10-Q · filed 2018-05-10
$0.00
derived: sum of 2 quarters · filed 2020-03-02
$233.00K
derived: sum of 3 quarters · filed 2020-03-02
$80.00K
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$233.00K
derived: sum of 2 quarters · filed 2020-03-02
$80.00K
derived: sum of 3 quarters · filed 2020-03-02
-$162.00K
10-K · filed 2020-03-02
-$161.73K
10-K · filed 2018-03-15
2017-09-30$233.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$80.00K
derived: sum of 2 quarters · filed 2018-11-09
-$162.00K
10-Q · filed 2018-11-09
-$161.73K
10-Q · filed 2017-11-09
-$160.52K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30-$153.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$395.00K
10-Q · filed 2018-08-09
-$395.38K
10-Q · filed 2017-08-09
-$393.52K
derived: sum of 3 quarters · filed 2019-03-01
-$399.52K
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$242.00K
10-Q · filed 2018-05-10
-$242.37K
10-Q · filed 2017-05-10
-$240.52K
derived: sum of 2 quarters · filed 2019-03-01
-$246.52K
derived: sum of 3 quarters · filed 2019-03-01
-$231.66K
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31$1.48K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$4.52K
derived: sum of 2 quarters · filed 2019-03-01
$10.34K
derived: sum of 3 quarters · filed 2019-03-01
$5.00K
10-K · filed 2019-03-01
$4.78K
10-K · filed 2017-03-16
2016-09-30-$6.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$8.86K
derived: sum of 2 quarters · filed 2017-11-09
$3.52K
10-Q · filed 2017-11-09
$45.24K
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30$14.86K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$9.52K
10-Q · filed 2017-08-09
$51.24K
derived: sum of 3 quarters · filed 2018-03-15
$51.24K
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31-$5.34K
10-Q · filed 2017-05-10
$36.38K
derived: sum of 2 quarters · filed 2018-03-15
$36.38K
derived: sum of 3 quarters · filed 2018-03-15
$62.29K
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31$41.72K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$41.72K
derived: sum of 2 quarters · filed 2018-03-15
$67.64K
derived: sum of 3 quarters · filed 2018-03-15
$41.72K
10-K · filed 2018-03-15
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$25.91K
derived: sum of 2 quarters · filed 2016-11-09
$0.00
10-Q · filed 2016-11-09
$13.87K
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$25.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$0.00
10-Q · filed 2016-08-09
$13.87K
derived: sum of 3 quarters · filed 2017-03-16
-$13.24K
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31-$25.91K
10-Q · filed 2016-05-10
-$12.04K
derived: sum of 2 quarters · filed 2017-03-16
-$39.16K
derived: sum of 3 quarters · filed 2017-03-16
-$17.21K
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$13.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
-$13.24K
derived: sum of 2 quarters · filed 2017-03-16
$8.71K
derived: sum of 3 quarters · filed 2017-03-16
$0.00
10-K · filed 2017-03-16
2014-09-30-$27.11K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$5.16K
derived: sum of 2 quarters · filed 2015-11-09
-$13.87K
10-Q · filed 2015-11-09
-$98.99K
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$21.95K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$13.24K
10-Q · filed 2015-08-10
-$71.88K
derived: sum of 3 quarters · filed 2016-03-15
-$76.81K
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31-$8.71K
10-Q · filed 2015-05-11
-$93.83K
derived: sum of 2 quarters · filed 2016-03-15
-$98.76K
derived: sum of 3 quarters · filed 2016-03-15
-$8.71K
derived: sum of 4 quarters · filed 2016-03-15
$76.42K
10-Q · filed 2014-05-14
2013-12-31-$85.12K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
-$90.06K
derived: sum of 2 quarters · filed 2016-03-15
$0.00
derived: sum of 3 quarters · filed 2016-03-15
$0.00
10-K · filed 2016-03-15
$85.12K
10-K · filed 2014-03-07
$85.12K
10-K · filed 2014-03-07
2013-09-30-$4.94K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
$85.12K
derived: sum of 2 quarters · filed 2014-11-14
$85.12K
10-Q · filed 2014-11-14
$85.12K
derived: sum of 4 quarters · filed 2014-11-14
$85.12K
10-Q · filed 2013-11-14
2013-06-30$90.06K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24
$90.06K
10-Q · filed 2014-07-24
$90.06K
derived: sum of 3 quarters · filed 2014-07-24
$90.06K
derived: sum of 4 quarters · filed 2014-07-24
$90.06K
10-Q · filed 2013-08-09
2013-03-31$0.00
10-Q · filed 2014-05-14
$0.00
derived: sum of 2 quarters · filed 2014-05-14
$0.00
derived: sum of 3 quarters · filed 2014-05-14
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07
$0.00
derived: sum of 2 quarters · filed 2014-03-07
$0.00
10-K · filed 2014-03-07
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
$0.00
10-Q · filed 2013-11-14
2012-06-30$0.00
10-Q · filed 2013-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20